These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7008743)

  • 21. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.
    Jeffery JR; Guttmann RD; Charpentier B
    Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfused cadaver kidney donors and graft survival.
    Frisk B; Berglin E; Brynger H
    Transplantation; 1983 Apr; 35(4):352-5. PubMed ID: 6340291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of kidneys from living related donors. Comparison with cadaveric kidney transplantation.
    Thomson NM; Atkins RC; Scott DF; Marshall VC; McGinley E; Holdsworth SR; Ironside W
    Med J Aust; 1983 Dec 10-24; 2(12):609-12. PubMed ID: 6366497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood transfusion and primary graft survival in male recipients.
    Brynger H; Frisk B; Ahlmén J; Blohmé I; Sandberg L
    Scand J Urol Nephrol Suppl; 1977; (42):76-8. PubMed ID: 356229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor pretreatment in cardiac allografts.
    Nowygrod R; Hardy MA; Todd GJ; Oluwole S; Reemtsma K
    Transplant Proc; 1979 Jun; 11(2):1462-4. PubMed ID: 382540
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of renal transplantation from cadavers in 200 patients].
    Cantaluppi A; Tarantino A; De Vecchi A; Montagnino G; Ponticelli C
    Minerva Chir; 1980 May; 35(10):761-4. PubMed ID: 7005732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 30. Graft survival and blood transfusion.
    Brynger H; Frisk B; Ahlmén J; Attman PO; Blohmé I; Sandberg L; Gelin LE
    Proc Eur Dial Transplant Assoc; 1977; 14():290-5. PubMed ID: 341128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of blood transfusions on kidney transplant and uremic patient survival.
    Solheim BG; Flatmark A; Jervell J; Arnesen E
    Scand J Urol Nephrol Suppl; 1977; (42):65-9. PubMed ID: 356226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL; van Breda Vriesman PJ
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract]   [Full Text] [Related]  

  • 33. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
    Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
    N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor age and recipient age.
    Takemoto S; Terasaki PI
    Clin Transpl; 1988; ():345-56. PubMed ID: 3154484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 37. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
    Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statewide donor pretreatment study.
    Dienst SG
    Transplant Proc; 1977 Sep; 9(3):1597-9. PubMed ID: 331595
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.